AC
LIVN icon

AMS Capital’s LivaNova LIVN Stock Holding History

AMS Capital’s Portfolio LIVN Stock Details LIVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,752
Closed -$589K – 31
2018
Q3 		$589K Buy
+4,752
New +$560K 0.49% 40

Other funds holding LIVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AMS Capital's LIVN Position: Q4 2018 in Review

AMS Capital sold out of LivaNova (LIVN) in Q4 2018, closing a stake of 4,752 shares — an estimated $589K sold.

AMS Capital first reported a position in LIVN in Q3 2018 and held it in 1 quarter. The position peaked at $589K in Q3 2018. 251 funds tracked by Wall St. Rank hold LIVN as of Q4 2018.

  • AMS Capital reported no remaining LivaNova position as of Q4 2018 after selling out during the quarter.
  • AMS Capital sold 4,752 LivaNova shares in Q4 2018, an estimated $589K.
  • AMS Capital first reported a position in LivaNova in Q3 2018 and held it in 1 quarter.
  • AMS Capital's LivaNova position peaked at $589K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held LivaNova as of Q4 2018.

Based on AMS Capital's 13F filing for Q4 2018, filed 29 Jan 2019.